63
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Prescription duration and treatment episodes in oral glucocorticoid users: application of the parametric waiting time distribution

, , , , , & show all
Pages 591-600 | Published online: 16 Nov 2017

References

  • PottegardASchmidtSAWallach-KildemoesHSorensenHTHallasJSchmidtMData resource profile: the Danish National Prescription RegistryInt J Epidemiol201746379827789670
  • NielsenLHLokkegaardEAndreasenAHKeidingNUsing prescription registries to define continuous drug use: how to fill gaps between prescriptionsPharmacoepidemiol Drug Saf200817438438818213736
  • SinnottSJPolinskiJMByrneSGagneJJMeasuring drug exposure: concordance between defined daily dose and days’ supply depended on drug classJ Clin Epidemiol20166910711326146090
  • StovringHPottegardAHallasJDetermining prescription durations based on the parametric waiting time distributionPharmacoepidemiol Drug Saf201625121451145927670969
  • BaysAMGardnerGPharmacologic therapies for rheumatologic and autoimmune conditionsMed Clin North Am2016100471973127235612
  • LaugesenKJorgensenJOLSorensenHTPetersenISystemic glucocorticoid use in Denmark: a population-based prevalence studyBMJ Open201775e015237
  • FardetLPetersenINazarethIPrevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 yearsRheumatology (Oxford)201150111982199021393338
  • ButtgereitFda SilvaJABoersMStandardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatologyAnn Rheum Dis200261871872212117678
  • SchmidtMPedersenLSorensenHTThe Danish Civil Registration System as a tool in epidemiologyEur J Epidemiol201429854154924965263
  • WHO Collaborating Centre for Drug Statistics MethodologyDefinition and general considerations Available from: https://www.whocc.no/ddd/definition_and_general_considera/Accessed January 13, 2017